Calidi Biotherapeutics (CLDWW) Q3 2024 Earnings

13AugConfirmed
Q3 2024
-1.45
-1.43
-1.42
-1.4

Details

Expected EPS
-1.45
Actual EPS
-1.4
Surprise EPS
0.05
Surprise Percent
+3.45%

Description

Calidi Biotherapeutics (CLDWW) has reported earnings of -1.4 per share for Q3 2024.

0 Comments

Share your thoughts